Tokio Marine Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.77M Buy
198,023
+7,223
+4% +$189K 0.15% 107
2026
Q1
$5.36M Buy
190,800
+1,935
+1% +$51.5K 0.19% 89
2025
Q4
$4.7M Buy
188,865
+7,641
+4% +$193K 0.16% 104
2025
Q3
$4.62M Buy
181,224
+7,482
+4% +$185K 0.16% 109
2025
Q2
$4.21M Buy
173,742
+5,996
+4% +$140K 0.16% 111
2025
Q1
$4.25M Buy
167,746
+9,670
+6% +$253K 0.15% 129
2024
Q4
$4.19M Buy
158,076
+3,557
+2% +$96.5K 0.15% 131
2024
Q3
$4.47M Buy
154,519
+12,937
+9% +$377K 0.2% 85
2024
Q2
$3.96M Buy
141,582
+4,457
+3% +$123K 0.19% 81
2024
Q1
$3.81M Buy
137,125
+7,718
+6% +$214K 0.19% 83
2023
Q4
$3.73M Buy
129,407
+5,859
+5% +$177K 0.21% 78
2023
Q3
$4.1M Buy
123,548
+8,350
+7% +$295K 0.26% 69
2023
Q2
$4.23M Buy
115,198
+6,973
+6% +$271K 0.27% 64
2023
Q1
$4.42M Buy
108,225
+16,361
+18% +$707K 0.31% 64
2022
Q4
$4.71M Buy
91,864
+8,695
+10% +$417K 0.37% 63
2022
Q3
$3.64M Buy
83,169
+8,449
+11% +$411K 0.31% 59
2022
Q2
$3.92M Buy
74,720
+8,157
+12% +$416K 0.35% 51
2022
Q1
$3.45M Buy
66,563
+1,680
+3% +$87.2K 0.27% 59
2021
Q4
$3.83M Buy
64,883
+3,647
+6% +$181K 0.3% 55
2021
Q3
$2.63M Buy
61,236
+6,477
+12% +$287K 0.23% 63
2021
Q2
$2.14M Sell
54,759
-998
-2% -$38.8K 0.2% 64
2021
Q1
$2.02M Buy
55,757
+9,469
+20% +$336K 0.21% 64
2020
Q4
$1.7M Buy
46,288
+10,609
+30% +$389K 0.19% 70
2020
Q3
$1.24M Buy
35,679
+3,856
+12% +$135K 0.15% 71
2020
Q2
$987K Buy
31,823
+4,086
+15% +$139K 0.14% 77
2020
Q1
$859K Sell
27,737
-2,518
-8% -$85.8K 0.15% 78
2019
Q4
$1.13M Sell
30,255
-9,737
-24% -$347K 0.17% 88
2019
Q3
$1.36M Sell
39,992
-11,988
-23% -$436K 0.23% 81
2019
Q2
$2.14M Sell
51,980
-12,962
-20% -$515K 0.37% 57
2019
Q1
$2.62M Buy
64,942
+1,974
+3% +$79.1K 0.49% 45
2018
Q4
$2.61M Sell
62,968
-1,276
-2% -$53K 0.53% 48
2018
Q3
$2.69M Sell
64,244
-12,076
-16% -$465K 0.47% 51
2018
Q2
$2.63M Buy
76,320
+2,401
+3% +$82K 0.48% 51
2018
Q1
$2.49M Sell
73,919
-49,239
-40% -$1.69M 0.44% 55
2017
Q4
$4.23M Sell
123,158
-14,989
-11% -$511K 0.64% 48
2017
Q3
$4.68M Sell
138,147
-11,427
-8% -$367K 0.7% 45
2017
Q2
$4.77M Sell
149,574
-21,046
-12% -$664K 0.68% 47
2017
Q1
$5.54M Sell
170,620
-52,989
-24% -$1.67M 0.73% 38
2016
Q4
$6.89M Sell
223,609
-531
-0.2% -$16.2K 0.79% 39
2016
Q3
$7.2M Buy
224,140
+33,031
+17% +$1.1M 0.78% 34
2016
Q2
$6.38M Sell
191,109
-6,118
-3% -$195K 0.66% 43
2016
Q1
$5.55M Buy
197,227
+3,217
+2% +$91.9K 0.56% 51
2015
Q4
$5.94M Sell
194,010
-42,117
-18% -$1.32M 0.66% 45
2015
Q3
$7.04M Sell
236,127
-132,728
-36% -$4.26M 0.74% 37
2015
Q2
$11.7M Sell
368,855
-37,763
-9% -$1.23M 1.15% 14
2015
Q1
$13.4M Buy
406,618
+107,210
+36% +$3.41M 1.24% 10
2014
Q4
$8.85M Sell
299,408
-102,620
-26% -$2.94M 0.77% 35
2014
Q3
$11.3M Sell
402,028
-39,613
-9% -$1.11M 0.82% 26
2014
Q2
$12.4M Sell
441,641
-298,586
-40% -$8.51M 0.84% 23
2014
Q1
$22.6M Sell
740,227
-39,351
-5% -$1.17M 1.46% 9
2013
Q4
$22.7M Sell
779,578
-78,161
-9% -$2.27M 1.41% 10
2013
Q3
$23.4M Sell
857,739
-111,128
-11% -$3.02M 1.49% 7
2013
Q2
$25.7M Buy
+968,867
New +$26.8M 1.63% 7

Other funds holding PFE

Tokio Marine Asset Management's PFE Position: Q2 2026 in Review

Tokio Marine Asset Management increased its Pfizer (PFE) stake by 3.8% in Q2 2026, buying an estimated $189K and bringing the position to 198,023 shares worth $4.77M. The position accounts for 0.15% of the portfolio, ranked #107.

Tokio Marine Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $25.7M in Q2 2013. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Tokio Marine Asset Management held 198,023 shares of Pfizer worth $4.77M as of Q2 2026.
  • Tokio Marine Asset Management bought 7,223 Pfizer shares in Q2 2026, an estimated $189K.
  • Pfizer made up 0.15% of Tokio Marine Asset Management's portfolio in Q2 2026, its #107 holding.
  • Tokio Marine Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Tokio Marine Asset Management's Pfizer position peaked at $25.7M in Q2 2013.
  • 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tokio Marine Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.